This brand name is authorized in Poland.
The drug AESCINER RETARD contains one active pharmaceutical ingredient (API):
1
|
UNII
3C18L6RJAZ - HORSE CHESTNUT
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C05CX03 | Hippocastani semen | C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CX Other capillary stabilizing agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| PL | Rejestru Produktów Leczniczych | 100088351 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.